Literature DB >> 6871830

Stratification of risk factors in renal cell carcinoma.

C Selli, W M Hinshaw, B H Woodard, D F Paulson.   

Abstract

One hundred fifteen patients underwent surgical treatment of renal cell carcinoma. Survival time was analyzed by statistical regression methods in order to determine the joint significance of stage, using both the Robson and TNM classifications, histologic grade, cell type, and demographic features of the patient sample. Grade and cell type were essentially interchangeable with respect to predicting survival in patients with and without metastatic disease. The strong association between these two factors explains and supports this result. The presence of metastases dramatically altered survival. Local extent of the tumor was an important indicator of survival in the nonmetastatic group of patients, but was not a statistically significant factor in those patients presenting with widespread disease. Venous involvement was not found to be of prognostic significance in either group. Age and weight loss contributed to predicting survival in the nonmetastatic patient group in addition to the measures of disease extent already discussed. Sex and race were not significant indicators of length of survival. In the group of patients with metastatic disease, no difference in survival was observed between soft tissue and bony metastases.

Entities:  

Mesh:

Year:  1983        PMID: 6871830     DOI: 10.1002/1097-0142(19830901)52:5<899::aid-cncr2820520526>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  [The WHO/ISUP grading system for renal carcinoma].

Authors:  H Moch
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

Review 2.  Perspectives in drug development for metastatic renal cell cancer.

Authors:  Bristi Basu; Tim Eisen
Journal:  Target Oncol       Date:  2010-08-06       Impact factor: 4.493

3.  Acridine orange flow cytometric analysis of renal cell carcinoma. Clinicopathologic implications of RNA content.

Authors:  A K el-Naggar; J G Batsakis; K Teague; G Giacco; V F Guinee; D Swanson
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

4.  Prognostic index of renal carcinomas.

Authors:  D L Répássy
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

Review 5.  Biology of metastasis and its clinical implications: renal-cell cancer.

Authors:  J C Ulchaker; E A Klein
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

6.  Significance of angiogenesis and microvascular invasion in renal cell carcinoma.

Authors:  Yoram Dekel; Rumelia Koren; Valentina Kugel; Pinhas M Livne; Rivka Gal
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

7.  Comparison of grading systems for estimating the prognosis of renal cell carcinoma.

Authors:  A Usubütün; M C Uygur; A Ayhan; C Toklu; A Sahin; H Ozen; S Ruacan
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

8.  Surgical treatment of renal cell carcinoma metastases: prognostic significance.

Authors:  M Takashi; Y Takagi; T Sakata; T Shimoji; K Miyake
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

9.  Renal cell carcinoma: correlation of CT findings with nuclear morphologic grading in 100 tumors.

Authors:  B A Birnbaum; M A Bosniak; G A Krinsky; D Cheng; J Waisman; M M Ambrosino
Journal:  Abdom Imaging       Date:  1994 May-Jun

Review 10.  Imaging in the staging of renal cell carcinoma.

Authors:  R H Reznek
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.